Publikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (17)

2022

  1. Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis

    Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163

2020

  1. A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells

    Journal of Clinical Medicine, Vol. 9, Núm. 3

  2. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430

2013

  1. Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

    Journal of Medical Genetics, Vol. 50, Núm. 1, pp. 25-33

  2. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

    Brain, Vol. 136, Núm. 6, pp. 1778-1782

  3. TNFRSF1A polymorphisms rs1800693 and rs4l49584 in patients with multiple sclerosis

    Neurology, Vol. 80, Núm. 22, pp. 2010-2016

2012

  1. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci

    Genes and Immunity, Vol. 13, Núm. 3, pp. 253-257

  2. Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

    Journal of Neuroimmunology, Vol. 245, Núm. 1-2, pp. 98-101

  3. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990

  4. Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects

    Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562

  5. Replication study of 10 genes showing evidence for association with multiple sclerosis: Validation of TMEM39A, IL12B and CLBL genes

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 959-965

2011

  1. IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

    Journal of Neuroimmunology, Vol. 239, Núm. 1-2, pp. 101-104

  2. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain

    Genes and Immunity, Vol. 12, Núm. 2, pp. 110-115

  3. Validation of IRF5 as multiple sclerosis risk gene: Putative role in interferon beta therapy and human herpes virus-6 infection

    Genes and Immunity, Vol. 12, Núm. 1, pp. 40-45

2010

  1. IFN-β pharmacogenomics in multiple sclerosis

    Pharmacogenomics, Vol. 11, Núm. 8, pp. 1137-1148

  2. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis

    Genes and Immunity, Vol. 11, Núm. 5, pp. 439-445

  3. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain

    Journal of Neuroimmunology, Vol. 223, Núm. 1-2, pp. 100-103